Santa Fe Precision Oncology Symposium
This accredited continuing education activity, Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.
Target Audience
- Hematologists/ Oncologists
- Oncology Fellows
- NPs/PAs
- Pharmacists
- Nurses
- Researchers and others
ORGANIZING COMMITTEE:
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair:
Fei Gu, MD, PhD - Nexus Health
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review the current and emerging paradigms in precision oncology and plan precision-guided management of various malignancies.
- Explain the roles, advantages, and disadvantages of different testing methodologies for guiding targeted therapies, including the appropriate timing for these tests.
- Interpret the concept of “tumor agnostic” therapeutics and identify opportunities to optimize treatment logistics and manage side effects across different malignancies.
- Identify collaboration opportunities among regional providers to optimize patient care through enhanced access to clinical trials available at cancer centers in the region.
HOTEL INFORMATION
A limited number of guestrooms are reserved at the Hilton Santa Fe Historic Plaza for the participants of this meeting at a discounted rate of $229.00 per night. The room rate does not include any additional fees or applicable taxes.
CUTOFF - Thursday, September 26, 2024
Please use the link below to reserve your room for the discounted rate. The rate is good through Thursday, September 26, 2024.
https://group.hilton.com/xzfqzj
Central Reservations number: 1.800.445.8667
If you call into central reservations to reserve the room, please refer to SF PRECISION.
Parking
$22.00 per vehicle
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
OCTOBER 19, 2024
All times are listed in Mountain Daylight Time (MDT)
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
07:30 AM – 07:35 AM Welcome
07:35 AM – 08:00 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:00 AM – 09:00 AM Session 1 - NGS & Beyond: Tools in Precision Oncology
Session Chair: Mohammad Vasef, MD
08:00 AM – 08:20 AM Tissue-Based NGS Testing - Y. Lynn Wang, MD, PhD, FCAP
08:20 AM – 08:40 AM Liquid Biopsy and ctDNA - Jordan Paul Redemann, MD
08:40 AM – 09:00 AM Case-Based Discussion - Mohammad Vasef, MD
09:00 AM – 10:30 AM Session 2 - Targeted Therapies
Session Chair: Ethan Binder, MD
09:00 AM – 09:20 AM Acute Leukemia: Where Do We Stand Now? - Musa Yilmaz, MD
09:20 AM – 09:40 AM Receptor Tyrosine Kinases: The NSCLC Story - Moises Harari Turquie , MD
09:40 AM – 10:00 AM The Hormonal Pathway and Overcoming Humoral Resistance: The HR+HER2- Story - Mei Wei, MD
10:00 AM – 10:30 AM Case-Based Discussion - Ines Sanchez-Rivera, MD
10:30 AM – 11:00 AM Break & Exhibits
11:00 AM – 12:00 PM Session 3 - Tumor Agnostic Treatment
Session Chair: Scott M. Herbert, MD
11:00 AM – 11:30 AM Keynote Speech - Clifton ‘Kip’ Layman, DO
11:30 AM – 12:00 PM Panel Discussion - Mei Wei, MD, Scott M. Herbert, MD & Clifton ‘Kip’ Layman, DO
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:00 PM Session 4 - Therapeutic Antibodies
Session Chair: Shashank Cingam, MD
01:00 PM – 01:20 PM Enfortumab in Bladder Cancer - Charles Jiang, MD, MPH
01:20 PM – 01:40 PM Bispecific Antibodies: Opportunities and Challenges - Adeel Khan, MD, MPH, MS
01:40 PM – 02:00 PM Panel Discussion /Q&A
02:00 PM – 03:00 PM Session 5 - Precision Oncology: Focus on Delivery
Session Chair: Malcolm Purdy, MD
02:00 PM – 02:20 PM IO in Early Stage Cancers - Shiruyeh Schokrpur, MD, PhD
02:20 PM – 02:40 PM Radionuclide in Diagnosis and Therapy - Anna-Maria Alicia De Costa MD, PhD
02:40 PM – 03:00 PM Panel Discussion /Q&A
03:00 PM – 03:30 PM Break & Exhibits
03:30 PM – 04:30 PM Session 6 - Managing Toxicities
Session Chair: Neda Hashemi, MD
03:30 PM – 03:50 PM Managing Side Effects in Oral Oncolytics - Jessica M. Lewis-Gonzalez, PharmD, BCOP & Mary T. Young, PharmD
03:50 PM – 04:10 PM Managing Toxicities of ADCs - Katherine Sanchez, MD
04:10 PM – 04:30 PM Panel Discussion/Q&A
04:30 PM – 05:15 PM Session 7 - Access to Clinical Trials
Session Chair: Bryan Goss, MD
04:30 PM – 04:45 PM Clinical Trial Design and Endpoints in the Era of Precision Oncology - Weijing Sun, MD, FACP
04:45 PM – 05:15 PM Panel Discussion - Gregg E. Franklin MD, PhD, Cheryl Sampson MBA, Clifton ‘Kip’ Layman, DO
05:15 PM Adjourn
HOTEL INFORMATION
A limited number of guestrooms are reserved at the Hilton Santa Fe Historic Plaza for the participants of this meeting at a discounted rate of $229.00 per night. The room rate does not include any additional fees or applicable taxes.
CUTOFF - Thursday, September 26, 2024
Please use the link below to reserve your room for the discounted rate. The rate is good through Thursday, September 26, 2024.
https://group.hilton.com/xzfqzj
Central Reservations number: 1.800.445.8667
If you call into central reservations to reserve the room, please refer to SF PRECISION.
Parking
$22.00 per vehicle
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Ethan Binder, MD
Shashank Cingam
Bryan Goss
Neda Hashemi
Malcolm Purdy
Mohammad Vasef, Academic pathologist, board certified by American Board of Pathology in AP/CP, Hematopathology, and Molecular Genetic Pathology
Anna-Maria De Costa
Moises Harari Turquie, MD
Changchuan(Charles) Jiang, MD, MPH
Adeel Khan, Adeel Khan, MD, MPH, MS
Clifton 'Kip' Layman, DO
Jessica Lewis-Gonzalez, PharmD, BCOP
Jordan Redemann, MD
Katherine Sanchez, MD
Shiruyeh Schokrpur, M.D., Ph.D.
Weijing Sun
Y. Wang
Mei Wei, MD
Musa Yilmaz
Mary Young, PharmD, BCOP
Gregg Franklin, MD, PhD
Cheryl Sampson, CCRP, MBA
Ines Sanchez Rivera, Area and Regional Medical Director Of Texas Oncology El Paso
Mohammad Vasef, Academic pathologist, board certified by American Board of Pathology in AP/CP, Hematopathology, and Molecular Genetic Pathology
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education Grant from:
- Novartis
Available Credit
- 7.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 7.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 7.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.